Category: Publications

Open letter to the European Commission on “Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States” (September 2016)

September 1, 2016 Press releases, Publications

13 September 2016 36 Civil Society Organisations have sent an Open letter to the European Commission urging the follow-up of the June 2016 EU Council Conclusions on "Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States »

EMA’s report on adaptive pathways: little data and much ado about nothing

August 31, 2016 Press releases, Publications

A joint press release issued by ISDB, MiEF and Nordic Cochrane Centre regarding the recently published report on EMA's controversial "adaptive pathways" pilot project. The report includes no new factual data, with no information shared about the drug's indications, type of clinical trial data to be submitted or which patient representatives were consulted. Read more…

EMA’s report on adaptive pathways: little data and much ado about nothing (August 2016)

August 1, 2016 Press releases, Publications

Brussels, 31 August 2016 In a joint press release, the International Society of Drug Bulletins, the Medicines in Europe Forum and the Nordic Cochrane Centre observe that EMA's report on "adaptive pathways" delivers little factual data but seems to indicate disappointing results for the controversial pilot project.

The need for a critical review of the intellectual property system and incentives for medical innovation (June 2016)

June 1, 2016 Press releases, Publications

Brussels, 2 June 2016 25 Civil Society organisations, including the Medicines in Europe Forum and the International Society of Drug Bulletins, call on Member States to resist pressure from the pharmaceutical industry to eliminate critical elements of proposed European Union (EU) Council Conclusions that would improve the balance between innovation and patients' access to affordable medicines.

Member States ought to support the Dutch EU Presidency’s vision on access to affordable medicines (April 2016)

April 1, 2016 Press releases, Publications

Amsterdam, 18 April 2016 20 civil society organisations including the Medicines in Europe Forum and ISDB announced their strong support for the Dutch European Union (EU) Presidency's critique of the current over-protection and misuse of intellectual property and related rights for pharmaceuticals. They also expressed support for efforts to better balance rewards for innovation against concerns over the affordability of medicines.

International Society of Drug Bulletins

Category: Publications

Open letter to the European Commission on “Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States” (September 2016)

EMA’s report on adaptive pathways: little data and much ado about nothing

EMA’s report on adaptive pathways: little data and much ado about nothing (August 2016)

The need for a critical review of the intellectual property system and incentives for medical innovation (June 2016)

Member States ought to support the Dutch EU Presidency’s vision on access to affordable medicines (April 2016)

Recent Publications

Newsletter

Sign up for our newsletter

Recent Campaigns